Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop (2010)
Chapter: INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS
Unfortunately, this book can't be printed from the OpenBook.
If you need to print pages from this book, we recommend
downloading it as a PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter:
Front Matter
Next Chapter: Appendix A Statement of Task
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Suggested Citation:
"INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ." National Research Council. 2010. Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches: Summary of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/12899.
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.